- Home
- NBIX vs AMH Comparison
NBIX vs AMH Comparison
Compare NBIX & AMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- AMH
- Stock Information
- Founded
- NBIX 1992
- AMH 2012
- Country
- NBIX United States
- AMH United States
- Employees
- NBIX N/A
- AMH N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- AMH Real Estate Investment Trusts
- Sector
- NBIX Health Care
- AMH Real Estate
- Exchange
- NBIX Nasdaq
- AMH Nasdaq
- Market Cap
- NBIX 14.4B
- AMH 12.1B
- IPO Year
- NBIX 1996
- AMH 2013
- Fundamental
- Price
- NBIX $154.77
- AMH $31.67
- Analyst Decision
- NBIX Strong Buy
- AMH Buy
- Analyst Count
- NBIX 18
- AMH 15
- Target Price
- NBIX $172.06
- AMH $39.07
- AVG Volume (30 Days)
- NBIX 1.0M
- AMH 3.1M
- Earning Date
- NBIX 10-28-2025
- AMH 10-29-2025
- Dividend Yield
- NBIX N/A
- AMH 3.80%
- EPS Growth
- NBIX 12.44
- AMH 23.05
- EPS
- NBIX 4.19
- AMH 1.18
- Revenue
- NBIX $2,682,700,000.00
- AMH $1,831,836,000.00
- Revenue This Year
- NBIX $23.68
- AMH $8.06
- Revenue Next Year
- NBIX $18.02
- AMH $4.44
- P/E Ratio
- NBIX $36.93
- AMH $26.78
- Revenue Growth
- NBIX 19.61
- AMH 7.71
- 52 Week Low
- NBIX $84.23
- AMH $31.01
- 52 Week High
- NBIX $157.67
- AMH $39.49
- Technical
- Relative Strength Index (RSI)
- NBIX 67.44
- AMH 36.75
- Support Level
- NBIX $133.62
- AMH $31.01
- Resistance Level
- NBIX $157.67
- AMH $32.43
- Average True Range (ATR)
- NBIX 4.47
- AMH 0.63
- MACD
- NBIX 1.07
- AMH -0.07
- Stochastic Oscillator
- NBIX 87.92
- AMH 26.57
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About AMH American Homes 4 Rent of Beneficial Interest
American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.